Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections.
The efficacy and tolerance of enoxacin were tested in 65 patients treated for ear, nose and throat infections with doses of 400 or 600 mg b.i.d. The overall clinical efficacy of enoxacin was excellent in 32, good in 17, fair in six, and poor in five out of 60 evaluable patients. Three female patients complained of stomach pressure and one man of slight nausea, two of allergic skin reactions and one of arthromyalgia. The pharmacokinetic studies showed high enoxacin concentrations in the secretions, pus, and tissues studied, especially in those of the middle ear and the sinuses.
Federspil
P J
PJ
Lind
A
A
Tiesler
E
E
Schmidt
B
B
D000328:Adult; D000890:Anti-Infective Agents / Q000378:metabolism / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D015365:Enoxacin; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D009287:Naphthyridines / Q000378:metabolism / Q000627:therapeutic use*; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D014018:Tissue Distribution
D000890:Anti-Infective Agents; D009287:Naphthyridines; D015365:Enoxacin